Neoleukin Therapeutics Price on May 13, 2024

NLTXDelisted Stock  USD 0.69  0.01  1.43%   
If you're considering investing in Neoleukin Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neoleukin Therapeutics stands at 0.69, as last reported on the 2nd of December, with the highest price reaching 0.71 and the lowest price hitting 0.67 during the day. We have found twenty-three technical indicators for Neoleukin Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Neoleukin Therapeutics' Standard Deviation of 3.7, risk adjusted performance of (0.03), and Mean Deviation of 2.25 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Neoleukin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
NLTX
Based on monthly moving average Neoleukin Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neoleukin Therapeutics by adding Neoleukin Therapeutics to a well-diversified portfolio.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Neoleukin Therapeutics Stock history

Neoleukin Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neoleukin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neoleukin Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neoleukin Therapeutics stock prices may prove useful in developing a viable investing in Neoleukin Therapeutics
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington. Neoleukin Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.

Neoleukin Therapeutics Stock Technical Analysis

Neoleukin Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Neoleukin Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neoleukin Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Neoleukin Therapeutics Period Price Range

Low
December 2, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Neoleukin Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Neoleukin Therapeutics December 2, 2024 Market Strength

Market strength indicators help investors to evaluate how Neoleukin Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neoleukin Therapeutics shares will generate the highest return on investment. By undertsting and applying Neoleukin Therapeutics stock market strength indicators, traders can identify Neoleukin Therapeutics entry and exit signals to maximize returns

Neoleukin Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neoleukin Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Neoleukin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neoleukin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Neoleukin Stock

If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings